ArticleSmall (Weinheim an der Bergstrasse, Germany)2026
Pure Chitosan Microfluidic Spinning Affords Modular Core-Sheath Fibers and Hand-Crafted Scaffolds with Enhanced Fibroblast Compatibility.
Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microfluidic-spun hydrogel fibers are appealing for tissue engineering and cell transplantation applications, as they give access to fiber-shaped tissues that mimic blood vessels, muscle fibers, or neural networks in vivo. Alginates are overwhelmingly employed as their base material, as they allow for simple processing, despite their poor cell adherence and weak cell-matrix interactions. Alginates also require crosslinking, and thus can leach ions and lose integrity under physiological conditions. To overcome these limitations, we are reporting herein the first synthesis of pure chitosan fibers by microfluidic wet spinning, avoiding the use of crosslinking agents, and achieving excellent cell viability of 85%. These fibers exhibit higher mechanical strength (695 MPa) than alginate counterparts (2-4 MPa). Our system can also accommodate a core of chitin nanocrystals to modulate mechanical properties or serve as a reservoir of bioactive molecules, such as methylene blue. As chitosan is a natural biopolymer, this work addresses the United Nations Sustainable Development Goals (UN SDGs) 6 and 14. The resulting pure chitosan and chitin/chitosan composite fibers exhibit high processability and can be woven into a variety of structures. Finally, these microstructured chitosan fibers have the potential to be used as templates to create fiber-shaped tissues or to develop into live building blocks for the assembly of very complex artificial tissues.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.